Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients

Marquette General Health System

Status: Withdrawn

Conditions: Glioma; Meningioma

Treatments: Procedure: Blood test

Study type: Observational

Funder types: Other

Identifiers

NCT00985036

MGH-VEGF-1

Details and patient eligibility

About

Objectives: This study is looking at the level of vascular endothelial growth factor (VEGF) circulating in the blood stream of patients diagnosed with either a meningioma or a glioma. The questions that will be addressed include:

1. Can VEGF level alert us to tumor progression or recurrence before MRI changes occur?
2. Is the VEGF level an indicator of the response to treatment?
3. Does the VEGF level correlate with tumor histology and behavior?
4. Is there a relationship between VEGF level and outcome?

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• any patient presenting with glioma or meningioma

Exclusion criteria

• a different type of brain tumor

Trial design

0 participants in 2 patient groups

Glioma

Description:

patients who are diagnosed with and are being treated for glioma

Treatment:

Procedure: Blood test

meningioma

Description:

patients who are diagnosed with and are being treated for meningioma

Treatment:

Procedure: Blood test